FIB-3 index and serum CK-18F level for monitoring suspected progression to metabolic dysfunction-associated steatohepatitis in biologic-controlled psoriasis: Two case reports and literature review on noninvasive markers.

Suzuki C, Miyagaki T, Go K, Kadono T, Watabe H

Open source

DOI
10.1016/j.jdcr.2026.07.068
Published
2026 Oct
Container
JAAD case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jdcr.2026.07.068,
  title = {FIB-3 index and serum CK-18F level for monitoring suspected progression to metabolic dysfunction-associated steatohepatitis in biologic-controlled psoriasis: Two case reports and literature review on noninvasive markers.},
  author = {Suzuki C and Miyagaki T and Go K and Kadono T and Watabe H},
  year = {2026},
  journal = {JAAD case reports},
  doi = {10.1016/j.jdcr.2026.07.068},
  url = {https://doi.org/10.1016/j.jdcr.2026.07.068}
}

RIS

TY  - JOUR
TI  - FIB-3 index and serum CK-18F level for monitoring suspected progression to metabolic dysfunction-associated steatohepatitis in biologic-controlled psoriasis: Two case reports and literature review on noninvasive markers.
AU  - Suzuki C
AU  - Miyagaki T
AU  - Go K
AU  - Kadono T
AU  - Watabe H
PY  - 2026
JO  - JAAD case reports
DO  - 10.1016/j.jdcr.2026.07.068
UR  - https://doi.org/10.1016/j.jdcr.2026.07.068
ER  - 

APA

C, S., T, M., K, G., T, K., & H, W. (2026). FIB-3 index and serum CK-18F level for monitoring suspected progression to metabolic dysfunction-associated steatohepatitis in biologic-controlled psoriasis: Two case reports and literature review on noninvasive markers.. JAAD case reports. https://doi.org/10.1016/j.jdcr.2026.07.068

Source records